Donate Now
Your gift is fully tax-deductible.
Harm reduction is a practical, non-judgmental approach that helps people who use drugs stay safer and healthier. It does not require someone to stop using before they receive support.
It provides practical tools that reduce overdose, infection, injury, and other risks related to drug use, and connects people with naloxone, testing, and other services close to home.
Signs of overdose: slow or stopped breathing, blue or gray lips or fingertips, unresponsive to voice or touch, gurgling or snoring sounds. If you see these signs, act right away.
Harm reduction is a practical, person-first approach to drug use. It meets people where they are, without requiring abstinence before help is offered.
Practical steps that lower the risk of overdose, injury, and infection.
Naloxone can reverse an opioid overdose. Keep it on hand, and make sure people around you know where it is and how to use it.
Fentanyl and xylazine test strips and drug checking can tell you more about what is actually in a substance. A negative test does not prove that a drug is safe.
Using alone increases the risk that an overdose goes unwitnessed. Having someone nearby, or on the phone, gives you a much better chance of getting help in time.
Potency can vary widely between bags, pills, powders, batches, and suppliers. No amount can be guaranteed safe, so starting with less and waiting matters.
Tolerance can drop quickly after abstinence, detox, residential treatment, incarceration, hospitalization, illness, or any period of reduced use. Returning to a prior amount can raise overdose risk.
Combining opioids with alcohol, benzodiazepines, or other sedating drugs increases overdose risk. When you can, avoid mixing depressants.
Don't share syringes, cookers, cotton, water, pipes, straws, or other use equipment. Sterile supplies reduce the risk of infection.
Wounds related to drug use can worsen quickly. Early attention matters more than waiting to see what happens.
Every link below opens our directory pre-filtered to that service.
Most states have Good Samaritan laws that give some legal protection from prosecution for drug possession when someone calls 911 for an overdose. Coverage varies by state, so it's worth checking your state's specific protections. These laws generally cover possession and consumption, not drug trafficking.
Source: FDA, CDC · Reviewed: September 20, 2026 · Reviewed by Scott Beach, LCDC
Fentanyl is now present in a wide range of illicit drug supplies, including counterfeit pills, and it can't be seen, smelled, or tasted. Drug checking covers a range of tools and services that give people more information about what's actually in a substance before they use it.
Check the instructions that came with your specific strips, since reading conventions can vary by brand.
Fentanyl test strips were classified as drug paraphernalia in some states. Most states have moved to legalize them in recent years, but rules still vary, so check your state's current law if you're uncertain, especially before traveling with them.
Source: CDC, NDEWS · Reviewed: September 20, 2026 · Reviewed by Penny Beach, PRS
Depending on the program, services may include:
Not every program offers every service. Check each listing for what's actually available.
Research on syringe service programs shows meaningfully reduced HIV and Hepatitis C transmission, without evidence that they increase drug use, and participants are more likely to enter treatment than people who don't use these programs.
Syringe service programs are generally confidential and non-judgmental. Most don't require ID to access services, and you won't be pressured to enter treatment, though staff can connect you when you're ready. Some programs offer one-for-one syringe exchange; others provide supplies without requiring a return. Check with the specific program for how they operate.
Source: CDC · Reviewed: September 20, 2026 · Reviewed by Penny Beach, PRS
Medication-assisted treatment (MAT), particularly buprenorphine, is itself a harm reduction tool. Someone doesn't need to be ready to stop using drugs entirely to benefit from it, and research shows it can meaningfully reduce overdose risk even if a person continues to use other substances.
Low-threshold programs are designed to remove common barriers to starting treatment:
Bridge prescribing is starting buprenorphine right away, such as in an emergency department or urgent care, before connecting someone to ongoing outpatient care. People who get a bridge prescription are more likely to still be in treatment a month later than those who only get a referral.
Low-dose induction (sometimes called micro-dosing) allows some people to start buprenorphine in small amounts while still using opioids, without waiting for withdrawal first. This can help people who can't tolerate standard induction.
Source: NIDA, SAMHSA · Reviewed: September 20, 2026 · Reviewed by Scott Beach, LCDC
Harm reduction isn't injection-only. Whether someone smokes, snorts, injects, or uses another route, the same core ideas apply: sharing equipment carries risk, and sterile, personal-use supplies lower it.
Wounds related to drug use should be evaluated early, especially if they're getting worse. Watch for:
Sharing syringes or other use equipment can expose blood to blood, which is how HIV and Hepatitis C spread among people who use drugs. Testing, prevention, and treatment are all available.
Direct-acting antiviral medications cure the large majority of Hepatitis C infections within 8-12 weeks, with minimal side effects. Reinfection is possible, but each infection remains curable, and treatment access does not require stopping drug use.
Source: CDC · Reviewed: September 20, 2026 · Reviewed by Scott Beach, LCDC
Using alone increases the risk that a fatal overdose goes unwitnessed. Options that help without requiring you to stop using alone:
Harm reduction vending machines give free, low-barrier access to supplies, and some are available 24/7. Contents vary by machine and program, and may include naloxone, fentanyl test strips, xylazine test strips, syringes, sharps containers, safer-use supplies, and wound-care supplies.
Some organizations mail naloxone to eligible individuals at no cost. Eligibility varies, programs may serve particular states, and availability changes over time.
Xylazine is a non-opioid sedative, sometimes called "tranq," increasingly identified in portions of the unregulated drug supply, often mixed with fentanyl.
Source: NIDA · Reviewed: September 20, 2026 · Reviewed by Scott Beach, LCDC
The unregulated drug supply keeps changing. Substances that public-health surveillance is currently watching include xylazine, medetomidine, nitazenes, carfentanil, and other synthetic opioids and adulterants. A single anecdotal report is not treated as a national trend. Any claim on this page is tied to a credible public-health or surveillance source, and unconfirmed findings are labeled as emerging signals, not established fact.
National provisional data has shown a downward trend in overdose deaths since the 2023 peak, though totals remain historically high. Synthetic opioids, primarily illicitly manufactured fentanyl, remain the leading driver of overdose deaths.
Source: CDC/NCHS provisional overdose data · Data period: rolling 12-month provisional counts · Reviewed: September 20, 2026 · Reviewed by Scott Beach, LCDC
Xylazine has been identified in portions of the illicit opioid supply in multiple parts of the country, most often combined with fentanyl.
Source: NIDA · Reviewed: September 20, 2026 · Reviewed by Scott Beach, LCDC
For current, exact figures, see the live CDC provisional overdose dashboard and NDEWS directly. Figures here are deliberately not hard-coded since they change monthly.
When credible public-health surveillance identifies a specific finding, including a substance, a place, and a date, it will appear here with its source and a practical recommendation. We do not publish a finding as a national trend based on a single anecdotal report.
Harm Reduction Finder prioritizes authoritative public-health sources for medical, scientific, epidemiological, and drug-supply claims on this page:
We separate established evidence from emerging signals, review fast-changing drug-supply information regularly, and do not treat a single social-media post or news article as proof of a national trend. We correct information when higher-quality evidence becomes available.
Last page review: September 20, 2026 · Reviewed by Scott Beach, LCDC and Penny Beach, PRS
Find naloxone, syringe services, test strips, drug checking, wound care, vending machines, and other harm reduction resources through Harm Reduction Finder.